Jazz Pharmaceuticals announces financial results for the third quarter of 2026

Summary

Broad commercial execution drives record quarterly revenues of $1.2 billion (+10% year-on-year) Company raises full year 2026 total revenue guidance ?? Ziihera® launched in HER2+ 1L mGEA Xywav® revenues grew 12%...